Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hironori Uruga

ALK (D5F3) CDx: An Immunohistochemistry Assay to Identify ALK-positive NSCLC Patients

Pharmacogenomics and Personalized Medicine

Molecular Medicine

English

Related publications

Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-positive Advanced NSCLC Patient

Molecular and Clinical Oncology

Cancer Research

English

Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion

Journal of Thoracic Oncology

Respiratory Medicine

English

Brigatinib Bei ALK-positivem NSCLC

Im Focus Onkologie

English

P2.13-06 TP53 Status in Relation to Response to Anti-Alk Agents in Patients With EML4-ALK-Translocated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Alectinib Provides a New Option for ALK-positive NSCLC Patients After Progression on Crizotinib

Journal of Community and Supportive Oncology

English

MA26.01 Accumulation of Concomitant Mutations Involved in Drug Resistance in the Sequential ALK TKI Treatments of ALK-Positive NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Neue Chance Bei ALK-positivem NSCLC

English

P1.01-101 Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn216 - Contemporary Real-World Evidences on Alk+ NSCLC Patients in Italy

Value in Health

Occupational Health

English